METTL3 and metastatic malignant neoplasm in the lymph nodes: A similar pattern was observed in regional lymph node metastasis, with an incidence of 29.03% for m6A regulators cluster 2 and 9.77% for m6A regulators cluster 3 (p<0.001, Figure 3H).